Noxopharm Ltd has released a press release.
Positive DARRT-1 Data in Late-Stage Prostate Cancer
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Noxopharm
- Lodgement of Nyrada Inc Prospectus - Initial Public Offering
- Noxopharm Announces Appointment of Chief Commercial Officer
- Appendix 4C - Quarterly
- Dr Graham Kelly to Assume CEO Role
- Durable Anti-Cancer Effect Confirmed in DARRT-1 Study
Later from Noxopharm
- Nyrada Inc Initial Public Offering Opens
- Lodgement of Nyrada Inc Supplementary Prospectus
- Nyrada IPO Offer Fully Subscribed
- DARRT-1 Clinical Data Webinar
- Listing of Nyrada Inc. spin-off on ASX
Follow Noxopharm into a list and get an email when it puts out news.
Follow Noxopharm